Die neue Sicht auf die Pathogenese der Parodontitis und daraus resultierende diagnostische und therapeutische Strategien

Die Sichtweise auf die Pathogenese der Parodontitis hat sich in den letzten Jahren deutlich verändert. Während man früher von einem rein infektiologischen (mikrobiologischen) Problem ausging (Plaquehypothese), wird heute die Parodontitis als eine chronisch entzündliche Erkrankung angesehen, die in ihrer Entstehung und Progression multifaktoriell bedingt ist. Auch wenn die Plaquebildung neben exogenen Risikofaktoren wie Rauchen, Stress und mangelnder Mundhygiene weiterhin den wichtigsten Kausalfaktor darstellt, weiß man heute, dass die individuelle Immunantwort eines Patienten entscheidend dafür ist, welche Folgen dieser auslösende Reiz (Biofilm) für den Entzündungsprozess hat.

• Literatur

• 1 Cullinan MP, Seymour GJ. Periodontal disease and systemic illness: will the evidence ever be enough?. Periodontol 2000 2013; 62: 271-286
• 2 Kornman KS, Crane A, Wang HY et al. The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997; 1: 72-77
• 3 Michalowicz BS, Aeppli D, Virag JG et al. Periodontal findings in adult twins. J Periodontol 1991; 62: 293-299
• 4 van der Velden U, Abbas F, Armand S et al. The effect of sibling relationship on the periodontal condition. J Clin Periodontol 1993; 9: 683-690
• 5 Fox SW, Fuller K, Chambers TJ. Activation of osteoclasts by interleukin-1: divergent responsiveness in osteoclasts formed in vivo and in vitro. J Cell Physiol 2000; 3: 334-340
• 6 Le XK, Laflamme C, Rouabhia M. Porphyromonas gingivalis decreases osteoblast proliferation through IL-6-RANKL/OPG and MMP-9/TIMPs pathways. Indian J Dent Res 2009; 2: 141-149
• 7 Sorsa T, Tjäderhane L, Konttinen YT et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann Med 2006; 5: 306-321
• 8 Abu-Saleh T. Interleukin-1 composite polymorphism as a risk factor for chronic periodontitis: a review. SADJ 2010; 65: 164-166
• 9 Grigoriadou ME, Koutayas SO, Madianos PN et al. Interleukin-1 as a genetic marker for periodontitis: review of the literature. Quintessence Int 2010; 41: 517-525
• 10 Stashenko P, Dewhirst FE, Peros WJ et al. Synergistic interactions between interleukin 1, tumor necrosis factor, and lymphotoxin in bone resorption. J Immunol 1987; 5: 1464-1468
• 11 Masada MP, Persson R, Kenney JS et al. Measurement of interleukin-1α and -1β in gingival crevicular fluid: implication for the pathogenesis of periodontal disease. J Periodont Res 1990; 25: 156-163
• 12 Engebretson S, Chertog R, Nichols A et al. Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes. Journal of Clinical Periodontology 2007; 34: 18-24
• 13 Ferreira SB, Trombone AP, Repeke CE et al. An interleukin-1beta (IL-1beta) single-nucleotide polymorphism at position 3954 and red complex periodontopathogens independently and additively modulate the levels of IL-1beta in diseased periodontal tissues. Infect Immun 2008; 76: 3725-3734
• 14 Shirodaria S, Smith J, McKay IJ et al. Polymorphisms in the IL-1 A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res 2000; 11: 1864-1869
• 15 Wilson AG, Symons JA, McDowell TL et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci 1997; 94: 3195-3199
• 16 Galbraith GM, Steed RB, Sanders JJ et al. Tumor necrosis factor alpha production by oral leukocytes: influence of tumor necrosis factor genotype. J Periodontol 1998; 69: 428-433
• 17 Deng JS, Qin P, Li XX et al. Association between interleukin-1β C (3953/4)T polymorphism and chronic periodontitis: evidence from a meta-analysis. Hum Immunol 2013; 74: 371-378
• 18 Mao M, Zeng XT, Ma T et al. Interleukin-1α -899 (+4845) C→T polymorphism increases the risk of chronic periodontitis: evidence from a meta-analysis of 23 case-control studies. Gene 2013; 532: 114-119
• 19 Ding C, Ji X, Chen X et al. TNF-α gene promoter polymorphisms contribute to periodontitis susceptibility: evidence from 46 studies. J Clin Periodontol 2014; 41: 748-759
• 20 Ding C, Zhao L, Sun Y et al. Interleukin-1 receptor antagonist polymorphism (rs2234663) and periodontitis susceptibility: a meta-analysis. Arch Oral Biol 2012; 57: 585-593
• 21 Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther 2006; 8 (Suppl. 02) S2
• 22 Moreira PR, Lima PM, Sathler KO et al. Interleukin-6 expression and gene polymorphism are associated with severity of periodontal disease in a sample of Brazilian individuals. Clin Exp Immunol 2007; 148: 119-126
• 23 Gu W, Du DY, Huang J et al. Identification of interleukin-6 promoter polymorphisms in the Chinese Han population and their functional significance. Crit Care Med 2008; 36: 1437-1443
• 24 Nibali L, Tonetti MS, Ready D et al. Interleukin-6 polymorphisms are associated with pathogenic bacteria in subjects with periodontitis. J Periodontol 2008; 79: 677-683
• 25 Teixeira G, Mendonça SA, Menezes Oliveira K et al. Interleukin-6 c.-174 G>C Polymorphism and Periodontitis in a Brazilian Population. Mol Biol Int 2014; 2014: 490308
• 26 Crawley E, Kay R, Sillibourne J et al. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101-1108
• 27 Zhong Q, Ding C, Wang M et al. Interleukin-10 gene polymorphisms and chronic/aggressive periodontitis susceptibility: a meta-analysis based on 14 case-control studies. Cytokine 2012; 60: 47-54
• 28 Claudino M, Trombone AP, Cardoso CR et al. The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J Leukoc Biol 2008; 84: 1565-1573